New York, New York-- (Newsfile Corp. - April 1, 2025) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Actinium Pharmaceuticals, Inc.

Recently, the National Medical Products Administration (NMPA) issued the draft version of 'Implementation Measures for Drug Trial Data ...

The FDA has accepted for Priority Review the BLA for apitegromab for the improvement of motor function in patients with spinal muscular atrophy.

Q4 2024 Earnings Call Transcript March 31, 2025 Omeros Corporation beats earnings expectations. Reported EPS is $-0.54, ...

Security forces have suffered heavy losses, with 56 personnel killed between March 2 and March 20, per the Pakistan Institute for Conflict and Security Studies. Meanwhile, Baloch separatists have ...

A BLA has been filed for bentracimab and, if approved, has the potential to be the first therapy to reverse the effects of ...

For decades, Pakistan’s military has manipulated democracy while maintaining a facade of stability. That illusion is now ...

Pakistan sees highest number of militant attacks during Ramadan in decade - Pakistan saw at least 84 attacks during Ramadan ...

Despite a significant net loss, Omeros Corp (OMER) focuses on strategic partnerships and a promising pipeline to bolster its ...